NLRP3 (NLR Family Pyrin Domain Containing 3)

NLRP3 (NLR Family Pyrin Domain Containing 3)

Overview

Nlrp3 (Nlr Family Pyrin Domain Containing 3) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

{{#vardefine:wikiId|}}
{{#vardefine:pageId|2213}}

<div class="infobox infox-protein">
<div class="infobox-header">NLRP3 (NLR Family Pyrin Domain Containing 3)</div>
<div class="infobox-image">

NLRP3 (NLR Family Pyrin Domain Containing 3)

Overview

Nlrp3 (Nlr Family Pyrin Domain Containing 3) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

{{#vardefine:wikiId|}}
{{#vardefine:pageId|2213}}

<div class="infobox infox-protein">
<div class="infobox-header">NLRP3 (NLR Family Pyrin Domain Containing 3)</div>
<div class="infobox-image">

</div>
<table class="infobox-table">
<tr><th>Protein Name</th><td>NLRP3</td></tr>
<tr><th>Gene Symbol</th><td>[NLRP3](/genes/nlrp3)</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q9NPF4" target="_blank">Q9NPF4</a></td></tr>
<tr><th>PDB Structures</th><td>4KXF, 6N8P, 7AL0</td></tr>
<tr><th>Molecular Weight</th><td>~118 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, inflammasome complex</td></tr>
<tr><th>Protein Family</th><td>NOD-like receptor family</td></tr>
<tr><th>Aliases</th><td>NLRP3, CIAS1, PYPAF1, NALP3, Cryopyrin</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's" style="color:#ef9a9a">ALZHEIMER'S</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2293 edges</a></td>
</tr>
</table>
</div>

Introduction

[NLRP3](/proteins/nlrp3) (NLR Family Pyrin Domain Containing 3) is a pattern recognition receptor that forms the [NLRP3 inflammasome](/entities/nlrp3-inflammasome), a multi-protein complex that activates caspase-1 and triggers the release of pro-inflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome is a central driver of neuroinflammation in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

Structure

NLRP3 contains three functional domains:

• PYD (N-terminal): Pyrin domain for homotypic interactions with ASC
• NACHT: Central nucleotide-binding domain responsible for oligomerization and ATP hydrolysis
• LRR (C-terminal): Leucine-rich repeat domain for ligand sensing

• NLRP3 (sensor)
• ASC (adaptor, encoded by PYCARD)
• Pro-caspase-1 (effector)

Normal Function

In the healthy nervous system, NLRP3:

• Provides innate immune surveillance
• Responds to pathogen-associated molecular patterns (PAMPs)
• Initiates inflammatory responses to cellular stress
• Facilitates tissue repair

Role in Disease

Alzheimer's Disease

NLRP3 contributes to AD pathogenesis through:

Parkinson's Disease

In PD, NLRP3 mediates:

• [α-Synuclein](/proteins/alpha-synuclein)-Induced Inflammation: NLRP3 is activated by α-synuclein aggregates
• Dopaminergic [Neuron](/entities/neurons) Death: IL-1β and IL-18 contribute to nigral neuron loss
• Microglial Activation: Sustained neuroinflammation in substantia nigra
• Mitochondrial DNA Sensing: NLRP3 recognizes mitochondrial DAMPs

Other Neurodegenerative Diseases

• Amyotrophic Lateral Sclerosis (ALS): NLRP3 activation in [microglia](/cell-types/microglia) and [astrocytes](/entities/astrocytes)
• Multiple Sclerosis: Contributes to demyelination and lesion progression
• Traumatic Brain Injury: Mediates post-traumatic neuroinflammation
• Huntington's Disease: NLRP3 activation exacerbates mutant [huntingtin](/proteins/huntingtin-protein) toxicity

Signaling Pathways

NLRP3 inflammasome activation follows a two-step priming and activation model:

Therapeutic Targeting

NLRP3 inflammasome inhibitors are actively being developed:

| Strategy | Compound | Status | Notes |
|----------|----------|--------|-------|
| NLRP3 inhibitors | MCC950 | Preclinical/Phase I | Direct NLRP3 ATPase inhibition |
| | Dapansutrile (OLT1177) | Phase II | β-sulfonyl nitrile compound |
| | Tranilast | Approved (allergy) | Repurposed for NLRP3 |
| IL-1β targeting | Anakinra, Canakinumab | Approved | IL-1 receptor antagonist |
| ASC inhibition | Small molecules | Research | Block inflammasome assembly |
| Caspase-1 inhibitors | VX-765 | Clinical trials | Prevent cytokine activation |

Biomarker Potential

NLRP3-related biomarkers under investigation:

• IL-1β in CSF: Marker of inflammasome activation
• ASC specks: Inflammasome activity in extracellular vesicles
• NLRP3 gene variants: Genetic modifiers of disease risk

Key Publications

Cross-Links

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
• ["NLRP3 Gene"](/proteins/nlrp3-protein)
• ["IL1B Gene"](/proteins/il1b-protein)
• ["IL-1β"](/il1b-gene---interleukin-1-beta)
• [Alpha-Synuclein Aggregation](/mechanisms/alpha-synuclein-aggregation-pathway)

Overview

Nlrp3 (Nlr Family Pyrin Domain Containing 3) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Nlrp3 (Nlr Family Pyrin Domain Containing 3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• cGAS-STING Pathway
• "Microglia in Neurodegeneration"
• "IL-1β as Biomarker"

Brain Atlas Resources

The following resources from the Allen Brain Atlas provide expression and connectivity data for this protein/gene:

• [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=NLRP3): Searchable gene expression database from adult human brain
• [Allen Brain Atlas - RNA Sequencing](https://human.brain-map.org/rnasearch): RNA sequencing data across brain regions
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/): Single-cell transcriptomic data for cell type classification
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Comprehensive mouse brain gene expression database
• [BrainSpan Atlas of the Developing Human Brain](https://www.brainspan.org/): Developmental expression data across brain regions and ages

External Links

• [UniProt: NLRP3](https://www.uniprot.org/uniprot/Q9NPF4)
• [NLRP3 Inflammasome Review](https://pubmed.ncbi.nlm.nih.gov/)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#ffd54f;font-weight:600">0.58</span> · Target: NLRP3, CASP1, IL1B, PYCARD

Pathway Diagram

The following diagram shows the key molecular relationships involving NLRP3 (NLR Family Pyrin Domain Containing 3) discovered through SciDEX knowledge graph analysis: